FDA issued a Warning Letter to PCI Synthesis on 12/2/2010 for a previous inspection.
483 PolyCarbon Industries Sep 2013

483 PolyCarbon Industries Sep 2013

$119 - Not in Stock

FDA investigators audited the PolyCarbon Industries - Newburyport, MA, United States facility and issued inspectional observations (via FDA 483) on 05 Sep 2013.

Product details

  • Category: Human Drugs
  • Inspection end: 05 Sep 2013
  • Location: Newburyport, United States
  • FEI: 1000513517
Order